SCHEMBL21647148

SCHEMBL21647148

Nc1ccc2c(=O)c(Cl)c(-c3ccc(N4CCCCC4)cc3)oc2c1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 1/20 0.40
▸ IP6K1 Q92551 2/20 0.38
▸ IP6K3 Q96PC2 1/20 0.38
▸ IP6K2 Q9UHH9 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ GAA P10253 3/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ THRB P10828 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15551009 0.75 CYP1A1 (0.52) TERT
SCHEMBL21668590 0.71 CDK2 (0.54) TERTALDH1A1MEN1KMT2AMAPT
SCHEMBL21647174 0.68 ALDH1A1 (0.47) TERTALDH1A1HTTGAAL3MBTL1
SCHEMBL21647180 0.68 TERT (0.62) TERTIP6K1IP6K3IP6K2MAPT
SCHEMBL22789251 0.68 TERT (0.44) TERTIP6K1IP6K3IP6K2MAPT
SCHEMBL23473440 0.67 TERT (0.40) TERTIP6K1IP6K3IP6K2ALDH1A1
SCHEMBL21668603 0.67 ABCG2 (0.49) TERTALDH1A1MEN1KMT2AMAPT
SCHEMBL23473389 0.66 CDK2 (0.44) IP6K1IP6K3IP6K2ALDH1A1MEN1
SCHEMBL14697003 0.66 ABCG2 (0.69) ALDH1A1MEN1KMT2AALOX15USP2
SCHEMBL21668602 0.65 ABCG2 (0.47) TERTALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110790739-B Compounds for treating neurological diseases and uses thereof 陕西麦科奥特科技有限公司 2021-10-01 — — CN disclosed
EP-3831821-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF Shaanxi Micot Technology Limited Company (CN) 2021-06-09 — — EP disclosed
EP-3831821-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF Shaanxi Micot Technology Limited Company (CN) 2021-06-09 — — EP disclosed
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) 2020-12-17 — — US disclosed
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) 2020-12-17 — — US disclosed
CN-110790739-A Compounds for treating neurological diseases and uses thereof 陕西麦科奥特科技有限公司 2020-02-14 — — CN disclosed
WO-2020024977-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF 陕西麦科奥特科技有限公司 2020-02-06 — — WO disclosed
WO-2020024977-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF 陕西麦科奥特科技有限公司 2020-02-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF MAPT, PYGB, SLC6A2 TERT 1839/4885IP6K1 2125/4885IP6K3 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback